Basecamp Wealth Advisors’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
Other funds holding OM
BCM
PA
PHS
Basecamp Wealth Advisors's OM Position: Q2 2026 in Review
Basecamp Wealth Advisors increased its Outset Medical (OM) stake by 1.4% in Q2 2026, buying an estimated $4 and bringing the position to 74 shares worth $320. The position accounts for ﹤0.01% of the portfolio, ranked #1696.
Basecamp Wealth Advisors first reported a position in OM in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.
- Basecamp Wealth Advisors held 74 shares of Outset Medical worth $320 as of Q2 2026.
- Basecamp Wealth Advisors bought 1 Outset Medical share in Q2 2026, an estimated $4.
- Outset Medical made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1696 holding.
- Basecamp Wealth Advisors first reported a position in Outset Medical in Q1 2026 and has held it in 2 quarters since.
- 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.